Laurène Meyniel-Schicklin
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Laurène Meyniel-Schicklin | |
|---|---|
| Born | France[1] |
| Education | Master in Bioinformatics, University of Évry Val d'Essonne |
| Title | Head of Computational Biology[2] |
| Engineering career | |
| Discipline | Bioinformatics |
| Employer(s) | Enyo Pharma[1] |
Laurène Meyniel-Schicklin is a bioinformatics engineer who specializes in genomic data science.[1]
Career[edit]
In 2014 she co-founded Enyo Pharma where she conducts research on a drug discovery engine[2][1] which mimics viruses' ability to model the cellular functions of the host.[3] She previously worked as an engineer with Inserm and taught at the Catholic University of Lyon.[2]
Education[edit]
She holds a degree in Bioinformatics from the University of Évry Val d'Essonne.[2]
Awards and honors[edit]
Laurène was featured in Forbes' Top 50 Women in Tech 2018 list,[1] and she has been granted a patent.[4]
References[edit]
- ^ a b c d e Laurène Meyniel-Schicklin (Forbes profile)
- ^ a b c d Laurène Meyniel-Schicklin Engineer: Executive Profile & Biography - Bloomberg
- ^ Levée de fonds exceptionnelle de la société ENYO pharma, dont les co-fondateurs scientifiques sont chercheurs au CIRI - CIRI
- ^ United States Active US9168236B2, Vincent Lotteau; Patrice Andre & Laurene Meyniel-Schicklin et al., "Methods and pharmaceutical compositions for inhibiting influenza viruses replication", published 2015-10-27, issued 2015-10-27, assigned to Universite Claude Bernard Lyon 1 (UCBL) and Institut National de la Sante et de la Recherche Medicale INSERM
   | This article about a French biologist is a stub. You can help Wikipedia by expanding it. |